No abstract available
Keywords:
IFN-α; bevacizumab; neuroendocrine tumors; randomized trials; targeted therapies.
MeSH terms
-
Antineoplastic Agents / therapeutic use
-
Bevacizumab / therapeutic use
-
Guidelines as Topic
-
Humans
-
Interferon-alpha / therapeutic use*
-
Molecular Targeted Therapy
-
Neuroendocrine Tumors / drug therapy*
-
Randomized Controlled Trials as Topic
Substances
-
Antineoplastic Agents
-
Interferon-alpha
-
Bevacizumab